Korean Drug Co. Ltd (014570) — Cash Flow Quality Index
Korean Drug Co. Ltd (014570) has a Cash Flow Quality Index of 5.49x as of March 2026. Operating cash flow of ₩6.60 Billion exceeds net income of ₩1.20 Billion, indicating high earnings quality where cash backs reported profits. Explore Korean Drug Co. Ltd (014570) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Korean Drug Co. Ltd Cash Flow Quality Index (2014–2025)
Historical Cash Flow Quality Index for Korean Drug Co. Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Korean Drug Co. Ltd generate cash.
Annual Cash Flow Quality Index for Korean Drug Co. Ltd (2014–2025)
Year-by-year earnings quality comparison for Korean Drug Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.01x | ₩13.11 Billion | ₩6.51 Billion | ▲ +23.8% |
| 2024 | 1.63x | ₩4.87 Billion | ₩3.00 Billion | ▲ +224.7% |
| 2022 | 0.50x | ₩5.91 Billion | ₩11.81 Billion | ▼ -48.6% |
| 2021 | 0.97x | ₩8.81 Billion | ₩9.04 Billion | ▼ -41.9% |
| 2020 | 1.68x | ₩12.33 Billion | ₩7.36 Billion | ▲ +5.1% |
| 2019 | 1.59x | ₩6.21 Billion | ₩3.90 Billion | ▲ +80.7% |
| 2018 | 0.88x | ₩5.79 Billion | ₩6.56 Billion | ▲ +823.6% |
| 2017 | 0.10x | ₩447.20 Million | ₩4.68 Billion | ▼ -87.8% |
| 2016 | 0.78x | ₩3.96 Billion | ₩5.05 Billion | ▼ -77.3% |
| 2015 | 3.46x | ₩6.13 Billion | ₩1.77 Billion | ▲ +66.7% |
| 2014 | 2.07x | ₩4.46 Billion | ₩2.15 Billion | — |